Because CAFs can comprise up to 90% of tumor stromal cells 49 and since they contribute prominently to tumor growth and survival, it seemed prudent to explore whether our FAP ligand might be exploited to eradicate CAFs. The gene discussed is FAP; the disease is neoplasm.